EP Patent

EP4384514A1 — Process for making diaryl isoxazoline derivative

Assigned to Elanco US Inc · Expires 2024-06-19 · 2y expired

What this patent protects

The present disclosure provides processes for making enantiomerically pure compounds of formula (1), (1),.

USPTO Abstract

The present disclosure provides processes for making enantiomerically pure compounds of formula (1), (1),.

Drugs covered by this patent

Patent Metadata

Patent number
EP4384514A1
Jurisdiction
EP
Classification
—
Expires
2024-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Elanco US Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.